Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD)

Recruitment & Eligibility

Inclusion Criteria

Prior participation in pico-tesla pilot studies: NCT00779155 & NCT00863226
Willing and able to abstain from partaking in non-essential new treatments for Parkinson's disease symptoms during the course of participation of the study.
Will and able to abstain from all non-essential new medications that could affect PD and/or any of its associated symptoms for the duration of the study.
Willing to notify the investigator right away of any changes in medication use or therapies that is prescribed and deemed necessary by the subjects physicians.
Adequate contraceptive measures for female subjects
Capable of giving full written informed consent

Exclusion Criteria

Not a participant in IRC#'s 07102 or 07021
No active brain tumors, strokes, hydrocephalus
Chronic pain not associated with PD
Any other condition which might prevent subject from comfortably sitting for 1.5 hours
Consumption of medications that can produce Parkinsonism type symptoms
Major psychiatric disturbance
Epilepsy
HIv and other autoimmune disorders
Cancer within last 2 years
History of ECt
Diabetic neuropathy
Uncontrolled HTN
Advanced Pulmonary disease
Known heart conditions such as repetitive history of cardiac arrythmias
Previous surgeries for PD
Prosthetics comprised of ferrous materials
Stents, only where there is also cardiac arrythmias, CHF, advanced valvular stenosis, unstable vital signs, extensive ischemic damage to heart muscle as a result of one or more heart attacks.
Pacemakers
Uncontrolled, unstable, or untreated medical illnesses which might potentially significantly affect the patient's health in the opinion of the investigator
Consumption of more than 21 alcoholic drinks per week
Pregnant, breast feeding or planning pregnancy
Developmental disability or cognitive impairment
Inability to maintain regular medication regime
Inability to abstain from partaking in new non-essential PD tx., or medications
Not willing to report physician mandated changes in medication and/or treatment

Arm && Interventions

Group	Intervention	Description
Active Resonator magnetic field therapy	Resonator Device	Administration of active magnetic fields with the Resonator Device

Primary Outcome Measures

Name	Time	Method
Change in Parkinson's Disease Questionnaire-39 Single Index Score (PDQ-39SI)From Baseline to Study Endpoint of 11 Months	baseline and 11 months	The Parkinson's Disease Questionnaire (PDQ-39) is a 39-item quality of life questionnaire for patients with Parkinson's Disease (PD) that evaluates the 8 dimensions of mobility, activities of daily living, emotional well-being, stigma, social support, cognition, and communication. The PDQ-39 Single Index (SI) score is the weighted addition of scores on all 8 dimension and ranges from 0 (no disease impact) to 100 (severe disease impact).

Secondary Outcome Measures